nodes	percent_of_prediction	percent_of_DWPC	metapath
Lorazepam—TSPO—blood vessel—Alzheimer's disease	0.0102	0.0987	CbGeAlD
Lorazepam—Balance disorder—Rivastigmine—Alzheimer's disease	0.00661	0.00849	CcSEcCtD
Lorazepam—Hypothermia—Memantine—Alzheimer's disease	0.00659	0.00846	CcSEcCtD
Lorazepam—Body temperature decreased—Memantine—Alzheimer's disease	0.00659	0.00846	CcSEcCtD
Lorazepam—Thrombocytosis—Donepezil—Alzheimer's disease	0.00654	0.0084	CcSEcCtD
Lorazepam—Block heart—Memantine—Alzheimer's disease	0.00651	0.00836	CcSEcCtD
Lorazepam—Body temperature decreased—Rivastigmine—Alzheimer's disease	0.00644	0.00828	CcSEcCtD
Lorazepam—Hypothermia—Rivastigmine—Alzheimer's disease	0.00644	0.00828	CcSEcCtD
Lorazepam—GABRG2—forebrain—Alzheimer's disease	0.00636	0.0616	CbGeAlD
Lorazepam—Inappropriate antidiuretic hormone secretion—Memantine—Alzheimer's disease	0.00635	0.00816	CcSEcCtD
Lorazepam—Myoclonus—Memantine—Alzheimer's disease	0.00614	0.00789	CcSEcCtD
Lorazepam—Delirium—Galantamine—Alzheimer's disease	0.0061	0.00784	CcSEcCtD
Lorazepam—TSPO—embryo—Alzheimer's disease	0.00609	0.0589	CbGeAlD
Lorazepam—Myoclonus—Rivastigmine—Alzheimer's disease	0.006	0.00772	CcSEcCtD
Lorazepam—Aggression—Galantamine—Alzheimer's disease	0.00597	0.00767	CcSEcCtD
Lorazepam—UGT2B15—Tamoxifen metabolism—CYP2D6—Alzheimer's disease	0.00592	0.0577	CbGpPWpGaD
Lorazepam—Hyperventilation—Donepezil—Alzheimer's disease	0.00591	0.00759	CcSEcCtD
Lorazepam—GABRG2—telencephalon—Alzheimer's disease	0.00585	0.0566	CbGeAlD
Lorazepam—GABRA1—forebrain—Alzheimer's disease	0.00562	0.0544	CbGeAlD
Lorazepam—Atrioventricular block—Galantamine—Alzheimer's disease	0.00541	0.00695	CcSEcCtD
Lorazepam—Extrapyramidal disorder—Donepezil—Alzheimer's disease	0.0054	0.00694	CcSEcCtD
Lorazepam—TSPO—forebrain—Alzheimer's disease	0.00538	0.0521	CbGeAlD
Lorazepam—Paralysis—Memantine—Alzheimer's disease	0.00531	0.00683	CcSEcCtD
Lorazepam—Suicidal ideation—Memantine—Alzheimer's disease	0.00526	0.00677	CcSEcCtD
Lorazepam—Hyperventilation—Rivastigmine—Alzheimer's disease	0.00525	0.00674	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Galantamine—Alzheimer's disease	0.00525	0.00674	CcSEcCtD
Lorazepam—GABRA1—telencephalon—Alzheimer's disease	0.00517	0.05	CbGeAlD
Lorazepam—Suicidal ideation—Rivastigmine—Alzheimer's disease	0.00515	0.00662	CcSEcCtD
Lorazepam—Cystitis noninfective—Galantamine—Alzheimer's disease	0.00512	0.00659	CcSEcCtD
Lorazepam—Salivary hypersecretion—Galantamine—Alzheimer's disease	0.00509	0.00655	CcSEcCtD
Lorazepam—Mania—Memantine—Alzheimer's disease	0.00508	0.00652	CcSEcCtD
Lorazepam—Urinary incontinence—Galantamine—Alzheimer's disease	0.00507	0.00651	CcSEcCtD
Lorazepam—Cystitis—Galantamine—Alzheimer's disease	0.00507	0.00651	CcSEcCtD
Lorazepam—Ventricular arrhythmia—Memantine—Alzheimer's disease	0.00499	0.00641	CcSEcCtD
Lorazepam—TSPO—telencephalon—Alzheimer's disease	0.00495	0.0479	CbGeAlD
Lorazepam—Stupor—Memantine—Alzheimer's disease	0.00494	0.00635	CcSEcCtD
Lorazepam—Extrapyramidal disorder—Memantine—Alzheimer's disease	0.0049	0.0063	CcSEcCtD
Lorazepam—GABRB3—forebrain—Alzheimer's disease	0.00489	0.0473	CbGeAlD
Lorazepam—Extrapyramidal disorder—Rivastigmine—Alzheimer's disease	0.0048	0.00616	CcSEcCtD
Lorazepam—Bladder pain—Galantamine—Alzheimer's disease	0.00474	0.0061	CcSEcCtD
Lorazepam—Coagulopathy—Memantine—Alzheimer's disease	0.00474	0.00609	CcSEcCtD
Lorazepam—Coagulopathy—Rivastigmine—Alzheimer's disease	0.00464	0.00596	CcSEcCtD
Lorazepam—Aggression—Donepezil—Alzheimer's disease	0.00463	0.00595	CcSEcCtD
Lorazepam—Diclofenac—TTR—Alzheimer's disease	0.00457	0.286	CrCbGaD
Lorazepam—GABRB3—telencephalon—Alzheimer's disease	0.00449	0.0435	CbGeAlD
Lorazepam—Blood alkaline phosphatase increased—Galantamine—Alzheimer's disease	0.00438	0.00563	CcSEcCtD
Lorazepam—Apnoea—Memantine—Alzheimer's disease	0.00435	0.0056	CcSEcCtD
Lorazepam—Leukocytosis—Donepezil—Alzheimer's disease	0.00433	0.00556	CcSEcCtD
Lorazepam—Dysarthria—Donepezil—Alzheimer's disease	0.0043	0.00552	CcSEcCtD
Lorazepam—Delirium—Memantine—Alzheimer's disease	0.00429	0.00552	CcSEcCtD
Lorazepam—Apnoea—Rivastigmine—Alzheimer's disease	0.00426	0.00548	CcSEcCtD
Lorazepam—Aggression—Memantine—Alzheimer's disease	0.0042	0.0054	CcSEcCtD
Lorazepam—Delirium—Rivastigmine—Alzheimer's disease	0.0042	0.0054	CcSEcCtD
Lorazepam—Atrioventricular block—Donepezil—Alzheimer's disease	0.00419	0.00539	CcSEcCtD
Lorazepam—Aggression—Rivastigmine—Alzheimer's disease	0.00411	0.00528	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Donepezil—Alzheimer's disease	0.00407	0.00523	CcSEcCtD
Lorazepam—Thinking abnormal—Memantine—Alzheimer's disease	0.00403	0.00518	CcSEcCtD
Lorazepam—Cystitis noninfective—Donepezil—Alzheimer's disease	0.00397	0.0051	CcSEcCtD
Lorazepam—Salivary hypersecretion—Donepezil—Alzheimer's disease	0.00395	0.00507	CcSEcCtD
Lorazepam—Leukocytosis—Memantine—Alzheimer's disease	0.00393	0.00505	CcSEcCtD
Lorazepam—Cystitis—Donepezil—Alzheimer's disease	0.00393	0.00505	CcSEcCtD
Lorazepam—Urinary incontinence—Donepezil—Alzheimer's disease	0.00393	0.00505	CcSEcCtD
Lorazepam—Lethargy—Galantamine—Alzheimer's disease	0.00389	0.00499	CcSEcCtD
Lorazepam—Leukocytosis—Rivastigmine—Alzheimer's disease	0.00384	0.00494	CcSEcCtD
Lorazepam—Dysarthria—Rivastigmine—Alzheimer's disease	0.00382	0.00491	CcSEcCtD
Lorazepam—Atrioventricular block—Memantine—Alzheimer's disease	0.00381	0.00489	CcSEcCtD
Lorazepam—Respiratory failure—Memantine—Alzheimer's disease	0.00376	0.00483	CcSEcCtD
Lorazepam—Atrioventricular block—Rivastigmine—Alzheimer's disease	0.00372	0.00478	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Memantine—Alzheimer's disease	0.00369	0.00474	CcSEcCtD
Lorazepam—Respiratory failure—Rivastigmine—Alzheimer's disease	0.00368	0.00473	CcSEcCtD
Lorazepam—Bladder pain—Donepezil—Alzheimer's disease	0.00368	0.00472	CcSEcCtD
Lorazepam—Phosphatase alkaline increased—Rivastigmine—Alzheimer's disease	0.00361	0.00464	CcSEcCtD
Lorazepam—Cystitis noninfective—Memantine—Alzheimer's disease	0.00361	0.00463	CcSEcCtD
Lorazepam—Ataxia—Galantamine—Alzheimer's disease	0.00358	0.0046	CcSEcCtD
Lorazepam—Depressed level of consciousness—Memantine—Alzheimer's disease	0.00356	0.00458	CcSEcCtD
Lorazepam—Urinary incontinence—Memantine—Alzheimer's disease	0.00356	0.00458	CcSEcCtD
Lorazepam—Cystitis—Memantine—Alzheimer's disease	0.00356	0.00458	CcSEcCtD
Lorazepam—Cystitis noninfective—Rivastigmine—Alzheimer's disease	0.00353	0.00453	CcSEcCtD
Lorazepam—Salivary hypersecretion—Rivastigmine—Alzheimer's disease	0.00351	0.00451	CcSEcCtD
Lorazepam—Euphoric mood—Donepezil—Alzheimer's disease	0.00349	0.00449	CcSEcCtD
Lorazepam—Urinary incontinence—Rivastigmine—Alzheimer's disease	0.00349	0.00448	CcSEcCtD
Lorazepam—Cystitis—Rivastigmine—Alzheimer's disease	0.00349	0.00448	CcSEcCtD
Lorazepam—GABRG2—nervous system—Alzheimer's disease	0.00345	0.0334	CbGeAlD
Lorazepam—Blood alkaline phosphatase increased—Donepezil—Alzheimer's disease	0.00339	0.00436	CcSEcCtD
Lorazepam—Coma—Memantine—Alzheimer's disease	0.00337	0.00434	CcSEcCtD
Lorazepam—Bladder pain—Memantine—Alzheimer's disease	0.00334	0.00429	CcSEcCtD
Lorazepam—GABRG2—central nervous system—Alzheimer's disease	0.00333	0.0322	CbGeAlD
Lorazepam—Coma—Rivastigmine—Alzheimer's disease	0.0033	0.00424	CcSEcCtD
Lorazepam—Pulmonary oedema—Memantine—Alzheimer's disease	0.00329	0.00422	CcSEcCtD
Lorazepam—Bladder pain—Rivastigmine—Alzheimer's disease	0.00327	0.0042	CcSEcCtD
Lorazepam—GABRG2—cerebellum—Alzheimer's disease	0.00325	0.0315	CbGeAlD
Lorazepam—Pulmonary oedema—Rivastigmine—Alzheimer's disease	0.00321	0.00413	CcSEcCtD
Lorazepam—Mental disability—Memantine—Alzheimer's disease	0.0032	0.00412	CcSEcCtD
Lorazepam—Mental disability—Rivastigmine—Alzheimer's disease	0.00313	0.00403	CcSEcCtD
Lorazepam—Chlorthalidone—CA4—Alzheimer's disease	0.00313	0.196	CrCbGaD
Lorazepam—Sleep disorder—Memantine—Alzheimer's disease	0.0031	0.00398	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Memantine—Alzheimer's disease	0.00308	0.00396	CcSEcCtD
Lorazepam—GABRA1—nervous system—Alzheimer's disease	0.00305	0.0295	CbGeAlD
Lorazepam—Sleep disorder—Rivastigmine—Alzheimer's disease	0.00303	0.00389	CcSEcCtD
Lorazepam—Blood alkaline phosphatase increased—Rivastigmine—Alzheimer's disease	0.00301	0.00387	CcSEcCtD
Lorazepam—Disorientation—Memantine—Alzheimer's disease	0.003	0.00385	CcSEcCtD
Lorazepam—Hyponatraemia—Donepezil—Alzheimer's disease	0.00296	0.00381	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Donepezil—Alzheimer's disease	0.00295	0.00379	CcSEcCtD
Lorazepam—Osteoarthritis—Donepezil—Alzheimer's disease	0.00295	0.00379	CcSEcCtD
Lorazepam—GABRA1—central nervous system—Alzheimer's disease	0.00294	0.0284	CbGeAlD
Lorazepam—TSPO—nervous system—Alzheimer's disease	0.00292	0.0283	CbGeAlD
Lorazepam—Psychotic disorder—Donepezil—Alzheimer's disease	0.00288	0.0037	CcSEcCtD
Lorazepam—GABRA1—cerebellum—Alzheimer's disease	0.00287	0.0278	CbGeAlD
Lorazepam—Amnesia—Memantine—Alzheimer's disease	0.00285	0.00367	CcSEcCtD
Lorazepam—Irritability—Donepezil—Alzheimer's disease	0.00282	0.00362	CcSEcCtD
Lorazepam—TSPO—central nervous system—Alzheimer's disease	0.00281	0.0272	CbGeAlD
Lorazepam—Amnesia—Rivastigmine—Alzheimer's disease	0.00279	0.00359	CcSEcCtD
Lorazepam—Ataxia—Donepezil—Alzheimer's disease	0.00278	0.00357	CcSEcCtD
Lorazepam—TSPO—cerebellum—Alzheimer's disease	0.00275	0.0266	CbGeAlD
Lorazepam—Lethargy—Memantine—Alzheimer's disease	0.00273	0.00351	CcSEcCtD
Lorazepam—Liver function test abnormal—Donepezil—Alzheimer's disease	0.00272	0.0035	CcSEcCtD
Lorazepam—Hyponatraemia—Memantine—Alzheimer's disease	0.00269	0.00346	CcSEcCtD
Lorazepam—Bradycardia—Galantamine—Alzheimer's disease	0.00268	0.00345	CcSEcCtD
Lorazepam—Diplopia—Memantine—Alzheimer's disease	0.00268	0.00344	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Memantine—Alzheimer's disease	0.00268	0.00344	CcSEcCtD
Lorazepam—Osteoarthritis—Memantine—Alzheimer's disease	0.00268	0.00344	CcSEcCtD
Lorazepam—GABRB3—nervous system—Alzheimer's disease	0.00265	0.0257	CbGeAlD
Lorazepam—GABRG2—brain—Alzheimer's disease	0.00264	0.0256	CbGeAlD
Lorazepam—Hyponatraemia—Rivastigmine—Alzheimer's disease	0.00263	0.00338	CcSEcCtD
Lorazepam—Gastrointestinal haemorrhage—Rivastigmine—Alzheimer's disease	0.00262	0.00337	CcSEcCtD
Lorazepam—Osteoarthritis—Rivastigmine—Alzheimer's disease	0.00262	0.00337	CcSEcCtD
Lorazepam—Diplopia—Rivastigmine—Alzheimer's disease	0.00262	0.00337	CcSEcCtD
Lorazepam—Hallucination—Galantamine—Alzheimer's disease	0.00262	0.00337	CcSEcCtD
Lorazepam—Psychotic disorder—Memantine—Alzheimer's disease	0.00262	0.00336	CcSEcCtD
Lorazepam—Psychotic disorder—Rivastigmine—Alzheimer's disease	0.00256	0.00329	CcSEcCtD
Lorazepam—Irritability—Memantine—Alzheimer's disease	0.00256	0.00329	CcSEcCtD
Lorazepam—GABRB3—central nervous system—Alzheimer's disease	0.00255	0.0247	CbGeAlD
Lorazepam—Cardiac arrest—Memantine—Alzheimer's disease	0.00255	0.00327	CcSEcCtD
Lorazepam—Visual impairment—Galantamine—Alzheimer's disease	0.00254	0.00326	CcSEcCtD
Lorazepam—Ataxia—Memantine—Alzheimer's disease	0.00252	0.00324	CcSEcCtD
Lorazepam—GABRB3—cerebellum—Alzheimer's disease	0.0025	0.0242	CbGeAlD
Lorazepam—Cardiac arrest—Rivastigmine—Alzheimer's disease	0.00249	0.0032	CcSEcCtD
Lorazepam—UGT2B15—Biological oxidations—CYP46A1—Alzheimer's disease	0.00248	0.0242	CbGpPWpGaD
Lorazepam—Liver function test abnormal—Memantine—Alzheimer's disease	0.00247	0.00318	CcSEcCtD
Lorazepam—Ataxia—Rivastigmine—Alzheimer's disease	0.00246	0.00317	CcSEcCtD
Lorazepam—Liver function test abnormal—Rivastigmine—Alzheimer's disease	0.00242	0.00311	CcSEcCtD
Lorazepam—Arrhythmia—Galantamine—Alzheimer's disease	0.00235	0.00302	CcSEcCtD
Lorazepam—GABRA1—brain—Alzheimer's disease	0.00233	0.0226	CbGeAlD
Lorazepam—Tension—Galantamine—Alzheimer's disease	0.00225	0.00289	CcSEcCtD
Lorazepam—TSPO—brain—Alzheimer's disease	0.00223	0.0216	CbGeAlD
Lorazepam—Nervousness—Galantamine—Alzheimer's disease	0.00223	0.00286	CcSEcCtD
Lorazepam—Jaundice—Donepezil—Alzheimer's disease	0.00222	0.00285	CcSEcCtD
Lorazepam—Pancytopenia—Memantine—Alzheimer's disease	0.0022	0.00283	CcSEcCtD
Lorazepam—Vision blurred—Galantamine—Alzheimer's disease	0.00216	0.00278	CcSEcCtD
Lorazepam—Tremor—Galantamine—Alzheimer's disease	0.00215	0.00276	CcSEcCtD
Lorazepam—Erectile dysfunction—Memantine—Alzheimer's disease	0.00213	0.00274	CcSEcCtD
Lorazepam—Agitation—Galantamine—Alzheimer's disease	0.00211	0.00271	CcSEcCtD
Lorazepam—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.00209	0.00268	CcSEcCtD
Lorazepam—Bradycardia—Donepezil—Alzheimer's disease	0.00208	0.00267	CcSEcCtD
Lorazepam—Vertigo—Galantamine—Alzheimer's disease	0.00206	0.00265	CcSEcCtD
Lorazepam—Hallucination—Donepezil—Alzheimer's disease	0.00203	0.00261	CcSEcCtD
Lorazepam—GABRB3—brain—Alzheimer's disease	0.00203	0.0196	CbGeAlD
Lorazepam—Drowsiness—Rivastigmine—Alzheimer's disease	0.00202	0.0026	CcSEcCtD
Lorazepam—Convulsion—Galantamine—Alzheimer's disease	0.00199	0.00255	CcSEcCtD
Lorazepam—Hypertension—Galantamine—Alzheimer's disease	0.00198	0.00254	CcSEcCtD
Lorazepam—Visual impairment—Donepezil—Alzheimer's disease	0.00197	0.00253	CcSEcCtD
Lorazepam—Agranulocytosis—Memantine—Alzheimer's disease	0.00193	0.00248	CcSEcCtD
Lorazepam—Dry mouth—Galantamine—Alzheimer's disease	0.00191	0.00245	CcSEcCtD
Lorazepam—Confusional state—Galantamine—Alzheimer's disease	0.00189	0.00243	CcSEcCtD
Lorazepam—Bradycardia—Memantine—Alzheimer's disease	0.00189	0.00243	CcSEcCtD
Lorazepam—Bradycardia—Rivastigmine—Alzheimer's disease	0.00185	0.00237	CcSEcCtD
Lorazepam—Hallucination—Memantine—Alzheimer's disease	0.00184	0.00237	CcSEcCtD
Lorazepam—Thrombocytopenia—Galantamine—Alzheimer's disease	0.00183	0.00236	CcSEcCtD
Lorazepam—Chills—Donepezil—Alzheimer's disease	0.00183	0.00235	CcSEcCtD
Lorazepam—Tachycardia—Galantamine—Alzheimer's disease	0.00183	0.00235	CcSEcCtD
Lorazepam—Arrhythmia—Donepezil—Alzheimer's disease	0.00182	0.00234	CcSEcCtD
Lorazepam—Hallucination—Rivastigmine—Alzheimer's disease	0.0018	0.00232	CcSEcCtD
Lorazepam—Alopecia—Donepezil—Alzheimer's disease	0.0018	0.00232	CcSEcCtD
Lorazepam—Visual impairment—Memantine—Alzheimer's disease	0.00179	0.0023	CcSEcCtD
Lorazepam—Erythema—Donepezil—Alzheimer's disease	0.00178	0.00228	CcSEcCtD
Lorazepam—Hypotension—Galantamine—Alzheimer's disease	0.00175	0.00225	CcSEcCtD
Lorazepam—Visual impairment—Rivastigmine—Alzheimer's disease	0.00175	0.00225	CcSEcCtD
Lorazepam—Tension—Donepezil—Alzheimer's disease	0.00174	0.00224	CcSEcCtD
Lorazepam—Nervousness—Donepezil—Alzheimer's disease	0.00173	0.00222	CcSEcCtD
Lorazepam—Vision blurred—Donepezil—Alzheimer's disease	0.00168	0.00215	CcSEcCtD
Lorazepam—Tremor—Donepezil—Alzheimer's disease	0.00167	0.00214	CcSEcCtD
Lorazepam—Somnolence—Galantamine—Alzheimer's disease	0.00166	0.00214	CcSEcCtD
Lorazepam—Chills—Memantine—Alzheimer's disease	0.00166	0.00214	CcSEcCtD
Lorazepam—Arrhythmia—Memantine—Alzheimer's disease	0.00166	0.00213	CcSEcCtD
Lorazepam—Alopecia—Memantine—Alzheimer's disease	0.00164	0.00211	CcSEcCtD
Lorazepam—Agitation—Donepezil—Alzheimer's disease	0.00163	0.0021	CcSEcCtD
Lorazepam—Chills—Rivastigmine—Alzheimer's disease	0.00163	0.00209	CcSEcCtD
Lorazepam—Arrhythmia—Rivastigmine—Alzheimer's disease	0.00162	0.00208	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.00162	0.00208	CcSEcCtD
Lorazepam—Fatigue—Galantamine—Alzheimer's disease	0.00161	0.00207	CcSEcCtD
Lorazepam—Alopecia—Rivastigmine—Alzheimer's disease	0.0016	0.00206	CcSEcCtD
Lorazepam—Constipation—Galantamine—Alzheimer's disease	0.0016	0.00206	CcSEcCtD
Lorazepam—Vertigo—Donepezil—Alzheimer's disease	0.0016	0.00205	CcSEcCtD
Lorazepam—Tension—Memantine—Alzheimer's disease	0.00158	0.00204	CcSEcCtD
Lorazepam—Erythema—Rivastigmine—Alzheimer's disease	0.00158	0.00203	CcSEcCtD
Lorazepam—Nervousness—Memantine—Alzheimer's disease	0.00157	0.00201	CcSEcCtD
Lorazepam—Tension—Rivastigmine—Alzheimer's disease	0.00155	0.00199	CcSEcCtD
Lorazepam—Feeling abnormal—Galantamine—Alzheimer's disease	0.00154	0.00198	CcSEcCtD
Lorazepam—Convulsion—Donepezil—Alzheimer's disease	0.00154	0.00198	CcSEcCtD
Lorazepam—Hypertension—Donepezil—Alzheimer's disease	0.00153	0.00197	CcSEcCtD
Lorazepam—Nervousness—Rivastigmine—Alzheimer's disease	0.00153	0.00197	CcSEcCtD
Lorazepam—Vision blurred—Memantine—Alzheimer's disease	0.00152	0.00195	CcSEcCtD
Lorazepam—Tremor—Memantine—Alzheimer's disease	0.00151	0.00194	CcSEcCtD
Lorazepam—Amoxapine—HTR6—Alzheimer's disease	0.0015	0.0937	CrCbGaD
Lorazepam—Vision blurred—Rivastigmine—Alzheimer's disease	0.00149	0.00191	CcSEcCtD
Lorazepam—Agitation—Memantine—Alzheimer's disease	0.00148	0.00191	CcSEcCtD
Lorazepam—UGT2B15—Biological oxidations—MAOB—Alzheimer's disease	0.00148	0.0144	CbGpPWpGaD
Lorazepam—Dry mouth—Donepezil—Alzheimer's disease	0.00148	0.0019	CcSEcCtD
Lorazepam—Tremor—Rivastigmine—Alzheimer's disease	0.00148	0.0019	CcSEcCtD
Lorazepam—Confusional state—Donepezil—Alzheimer's disease	0.00146	0.00188	CcSEcCtD
Lorazepam—Agitation—Rivastigmine—Alzheimer's disease	0.00145	0.00186	CcSEcCtD
Lorazepam—Vertigo—Memantine—Alzheimer's disease	0.00145	0.00186	CcSEcCtD
Lorazepam—Infection—Donepezil—Alzheimer's disease	0.00144	0.00185	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—DOCK3—Alzheimer's disease	0.00144	0.014	CbGpPWpGaD
Lorazepam—Thrombocytopenia—Donepezil—Alzheimer's disease	0.00142	0.00183	CcSEcCtD
Lorazepam—Vertigo—Rivastigmine—Alzheimer's disease	0.00142	0.00182	CcSEcCtD
Lorazepam—Convulsion—Memantine—Alzheimer's disease	0.0014	0.0018	CcSEcCtD
Lorazepam—Hypertension—Memantine—Alzheimer's disease	0.00139	0.00179	CcSEcCtD
Lorazepam—Hypersensitivity—Galantamine—Alzheimer's disease	0.00138	0.00177	CcSEcCtD
Lorazepam—Convulsion—Rivastigmine—Alzheimer's disease	0.00137	0.00176	CcSEcCtD
Lorazepam—Hypertension—Rivastigmine—Alzheimer's disease	0.00136	0.00175	CcSEcCtD
Lorazepam—Hypotension—Donepezil—Alzheimer's disease	0.00136	0.00174	CcSEcCtD
Lorazepam—Dry mouth—Memantine—Alzheimer's disease	0.00134	0.00173	CcSEcCtD
Lorazepam—Asthenia—Galantamine—Alzheimer's disease	0.00134	0.00173	CcSEcCtD
Lorazepam—Chlorprothixene—HTR6—Alzheimer's disease	0.00134	0.0839	CrCbGaD
Lorazepam—Confusional state—Memantine—Alzheimer's disease	0.00133	0.00171	CcSEcCtD
Lorazepam—Dry mouth—Rivastigmine—Alzheimer's disease	0.00131	0.00169	CcSEcCtD
Lorazepam—Infection—Memantine—Alzheimer's disease	0.00131	0.00168	CcSEcCtD
Lorazepam—Confusional state—Rivastigmine—Alzheimer's disease	0.0013	0.00167	CcSEcCtD
Lorazepam—GABRB3—Orphan transporters—APOD—Alzheimer's disease	0.00129	0.0126	CbGpPWpGaD
Lorazepam—Somnolence—Donepezil—Alzheimer's disease	0.00129	0.00166	CcSEcCtD
Lorazepam—Thrombocytopenia—Memantine—Alzheimer's disease	0.00129	0.00166	CcSEcCtD
Lorazepam—Tachycardia—Memantine—Alzheimer's disease	0.00129	0.00165	CcSEcCtD
Lorazepam—Infection—Rivastigmine—Alzheimer's disease	0.00128	0.00165	CcSEcCtD
Lorazepam—GABRG2—Orphan transporters—APOD—Alzheimer's disease	0.00127	0.0124	CbGpPWpGaD
Lorazepam—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.00126	0.00162	CcSEcCtD
Lorazepam—Tachycardia—Rivastigmine—Alzheimer's disease	0.00126	0.00162	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.00125	0.00161	CcSEcCtD
Lorazepam—Fatigue—Donepezil—Alzheimer's disease	0.00125	0.00161	CcSEcCtD
Lorazepam—Pain—Donepezil—Alzheimer's disease	0.00124	0.00159	CcSEcCtD
Lorazepam—Constipation—Donepezil—Alzheimer's disease	0.00124	0.00159	CcSEcCtD
Lorazepam—Dizziness—Galantamine—Alzheimer's disease	0.00124	0.00159	CcSEcCtD
Lorazepam—Hypotension—Memantine—Alzheimer's disease	0.00123	0.00158	CcSEcCtD
Lorazepam—Hypotension—Rivastigmine—Alzheimer's disease	0.0012	0.00155	CcSEcCtD
Lorazepam—Feeling abnormal—Donepezil—Alzheimer's disease	0.0012	0.00154	CcSEcCtD
Lorazepam—Vomiting—Galantamine—Alzheimer's disease	0.00119	0.00153	CcSEcCtD
Lorazepam—Rash—Galantamine—Alzheimer's disease	0.00118	0.00152	CcSEcCtD
Lorazepam—Dermatitis—Galantamine—Alzheimer's disease	0.00118	0.00152	CcSEcCtD
Lorazepam—Headache—Galantamine—Alzheimer's disease	0.00117	0.00151	CcSEcCtD
Lorazepam—Somnolence—Memantine—Alzheimer's disease	0.00117	0.0015	CcSEcCtD
Lorazepam—Somnolence—Rivastigmine—Alzheimer's disease	0.00115	0.00147	CcSEcCtD
Lorazepam—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00114	0.00146	CcSEcCtD
Lorazepam—Fatigue—Memantine—Alzheimer's disease	0.00114	0.00146	CcSEcCtD
Lorazepam—Pain—Memantine—Alzheimer's disease	0.00113	0.00145	CcSEcCtD
Lorazepam—Constipation—Memantine—Alzheimer's disease	0.00113	0.00145	CcSEcCtD
Lorazepam—UGT2B15—Biological oxidations—PTGS1—Alzheimer's disease	0.00112	0.0109	CbGpPWpGaD
Lorazepam—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.00111	0.00143	CcSEcCtD
Lorazepam—Nausea—Galantamine—Alzheimer's disease	0.00111	0.00143	CcSEcCtD
Lorazepam—Fatigue—Rivastigmine—Alzheimer's disease	0.00111	0.00143	CcSEcCtD
Lorazepam—GABRA1—Orphan transporters—APOD—Alzheimer's disease	0.00111	0.0108	CbGpPWpGaD
Lorazepam—Constipation—Rivastigmine—Alzheimer's disease	0.0011	0.00142	CcSEcCtD
Lorazepam—Pain—Rivastigmine—Alzheimer's disease	0.0011	0.00142	CcSEcCtD
Lorazepam—UGT2B15—Biological oxidations—CYP2D6—Alzheimer's disease	0.0011	0.0107	CbGpPWpGaD
Lorazepam—Feeling abnormal—Memantine—Alzheimer's disease	0.00109	0.00139	CcSEcCtD
Lorazepam—Hypersensitivity—Donepezil—Alzheimer's disease	0.00107	0.00137	CcSEcCtD
Lorazepam—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.00106	0.00136	CcSEcCtD
Lorazepam—Asthenia—Donepezil—Alzheimer's disease	0.00104	0.00134	CcSEcCtD
Lorazepam—GABRB3—BDNF signaling pathway—DPYSL2—Alzheimer's disease	0.00103	0.00999	CbGpPWpGaD
Lorazepam—Clozapine—HTR6—Alzheimer's disease	0.000982	0.0615	CrCbGaD
Lorazepam—Hypersensitivity—Memantine—Alzheimer's disease	0.00097	0.00125	CcSEcCtD
Lorazepam—Dizziness—Donepezil—Alzheimer's disease	0.000959	0.00123	CcSEcCtD
Lorazepam—Hypersensitivity—Rivastigmine—Alzheimer's disease	0.000949	0.00122	CcSEcCtD
Lorazepam—Asthenia—Memantine—Alzheimer's disease	0.000945	0.00121	CcSEcCtD
Lorazepam—Asthenia—Rivastigmine—Alzheimer's disease	0.000924	0.00119	CcSEcCtD
Lorazepam—Vomiting—Donepezil—Alzheimer's disease	0.000922	0.00119	CcSEcCtD
Lorazepam—Rash—Donepezil—Alzheimer's disease	0.000915	0.00118	CcSEcCtD
Lorazepam—Dermatitis—Donepezil—Alzheimer's disease	0.000914	0.00117	CcSEcCtD
Lorazepam—Headache—Donepezil—Alzheimer's disease	0.000909	0.00117	CcSEcCtD
Lorazepam—GABRB3—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.000902	0.00879	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—CDK5—Alzheimer's disease	0.000889	0.00866	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.000886	0.00863	CbGpPWpGaD
Lorazepam—Dizziness—Memantine—Alzheimer's disease	0.000871	0.00112	CcSEcCtD
Lorazepam—Nausea—Donepezil—Alzheimer's disease	0.000862	0.00111	CcSEcCtD
Lorazepam—Dizziness—Rivastigmine—Alzheimer's disease	0.000852	0.0011	CcSEcCtD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA7—Alzheimer's disease	0.000845	0.00824	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Alzheimer's disease	0.000845	0.00824	CbGpPWpGaD
Lorazepam—Vomiting—Memantine—Alzheimer's disease	0.000837	0.00108	CcSEcCtD
Lorazepam—Rash—Memantine—Alzheimer's disease	0.00083	0.00107	CcSEcCtD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Alzheimer's disease	0.00083	0.00809	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA7—Alzheimer's disease	0.00083	0.00809	CbGpPWpGaD
Lorazepam—Dermatitis—Memantine—Alzheimer's disease	0.00083	0.00107	CcSEcCtD
Lorazepam—Headache—Memantine—Alzheimer's disease	0.000825	0.00106	CcSEcCtD
Lorazepam—Vomiting—Rivastigmine—Alzheimer's disease	0.000819	0.00105	CcSEcCtD
Lorazepam—Rash—Rivastigmine—Alzheimer's disease	0.000812	0.00104	CcSEcCtD
Lorazepam—Dermatitis—Rivastigmine—Alzheimer's disease	0.000812	0.00104	CcSEcCtD
Lorazepam—Headache—Rivastigmine—Alzheimer's disease	0.000807	0.00104	CcSEcCtD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—MAP2—Alzheimer's disease	0.000783	0.00763	CbGpPWpGaD
Lorazepam—Nausea—Memantine—Alzheimer's disease	0.000782	0.00101	CcSEcCtD
Lorazepam—GABRA1—Transmission across Chemical Synapses—SLC18A3—Alzheimer's disease	0.000774	0.00754	CbGpPWpGaD
Lorazepam—Nausea—Rivastigmine—Alzheimer's disease	0.000765	0.000984	CcSEcCtD
Lorazepam—Diclofenac—PTGS1—Alzheimer's disease	0.000736	0.0461	CrCbGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA7—Alzheimer's disease	0.000726	0.00707	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK1—Alzheimer's disease	0.000726	0.00707	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Alzheimer's disease	0.000719	0.007	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Alzheimer's disease	0.000706	0.00688	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—SLC18A3—Alzheimer's disease	0.000691	0.00673	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—SLC18A3—Alzheimer's disease	0.000679	0.00661	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TP73—Alzheimer's disease	0.000665	0.00648	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CHRNA7—Alzheimer's disease	0.000665	0.00648	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—YWHAQ—Alzheimer's disease	0.000644	0.00628	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—Alzheimer's disease	0.000641	0.00624	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—DHCR24—Alzheimer's disease	0.000637	0.0062	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000636	0.00619	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.000636	0.00619	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—Alzheimer's disease	0.000629	0.00613	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—GRIA1—Alzheimer's disease	0.000626	0.0061	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000624	0.00608	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.000624	0.00608	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIK2—Alzheimer's disease	0.000617	0.00601	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAPT—Alzheimer's disease	0.000611	0.00596	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—Alzheimer's disease	0.000607	0.00591	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000601	0.00586	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—Alzheimer's disease	0.000596	0.0058	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—SLC18A3—Alzheimer's disease	0.000593	0.00578	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000591	0.00575	CbGpPWpGaD
Lorazepam—Amoxapine—SLC6A4—Alzheimer's disease	0.000573	0.0359	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CHAT—Alzheimer's disease	0.000566	0.00551	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—EIF2S1—Alzheimer's disease	0.000558	0.00544	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Alzheimer's disease	0.000551	0.00537	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA1—Alzheimer's disease	0.00055	0.00536	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNA7—Alzheimer's disease	0.000546	0.00531	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GRIK1—Alzheimer's disease	0.000546	0.00531	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CA4—Alzheimer's disease	0.000541	0.00527	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Alzheimer's disease	0.000541	0.00527	CbGpPWpGaD
Lorazepam—Chlordiazepoxide—CYP2D6—Alzheimer's disease	0.000541	0.0339	CrCbGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.00054	0.00527	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.00054	0.00527	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000536	0.00522	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HSPD1—Alzheimer's disease	0.000532	0.00518	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000531	0.00517	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000531	0.00517	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.000526	0.00513	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—GAPDH—Alzheimer's disease	0.000522	0.00509	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNB2—Alzheimer's disease	0.000521	0.00507	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—ABCA7—Alzheimer's disease	0.000516	0.00503	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GAPDHS—Alzheimer's disease	0.000509	0.00496	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—PTK2B—Alzheimer's disease	0.000501	0.00488	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—NTRK2—Alzheimer's disease	0.000487	0.00475	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CHRNA7—Alzheimer's disease	0.000487	0.00474	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GRIK1—Alzheimer's disease	0.000487	0.00474	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ATP5A1—Alzheimer's disease	0.000483	0.0047	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000482	0.00469	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GRIK1—Alzheimer's disease	0.000478	0.00466	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CHRNA7—Alzheimer's disease	0.000478	0.00466	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CHRNB2—Alzheimer's disease	0.000478	0.00465	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	0.000474	0.00462	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000473	0.00461	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Alzheimer's disease	0.000473	0.00461	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	0.000465	0.00453	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHAT—Alzheimer's disease	0.000464	0.00452	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GRIK2—Alzheimer's disease	0.000464	0.00452	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	0.000463	0.00451	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLD3—Alzheimer's disease	0.00046	0.00448	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC24A4—Alzheimer's disease	0.00046	0.00448	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	0.000458	0.00446	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000456	0.00444	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	0.000455	0.00443	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—GRIN2B—Alzheimer's disease	0.000453	0.00441	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	0.00045	0.00438	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000448	0.00436	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HSD17B10—Alzheimer's disease	0.000441	0.0043	CbGpPWpGaD
Lorazepam—Amoxapine—HTR2A—Alzheimer's disease	0.00044	0.0276	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CHRNA4—Alzheimer's disease	0.000434	0.00423	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TF—Alzheimer's disease	0.000429	0.00418	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP46A1—Alzheimer's disease	0.000425	0.00414	CbGpPWpGaD
Lorazepam—Diclofenac—PTGS2—Alzheimer's disease	0.000421	0.0263	CrCbGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000419	0.00408	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CHRNA7—Alzheimer's disease	0.000418	0.00407	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GRIK1—Alzheimer's disease	0.000418	0.00407	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—NGFR—Alzheimer's disease	0.000418	0.00407	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000414	0.00404	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CHAT—Alzheimer's disease	0.000414	0.00403	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GRIK2—Alzheimer's disease	0.000414	0.00403	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GRIA1—Alzheimer's disease	0.000413	0.00403	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.000411	0.00401	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ND1—Alzheimer's disease	0.00041	0.004	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Alzheimer's disease	0.000407	0.00396	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000407	0.00396	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CHAT—Alzheimer's disease	0.000407	0.00396	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GRIK2—Alzheimer's disease	0.000407	0.00396	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—SLC6A4—Alzheimer's disease	0.000403	0.00393	CbGpPWpGaD
Lorazepam—Amoxapine—CYP2D6—Alzheimer's disease	0.000403	0.0252	CrCbGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Alzheimer's disease	0.000398	0.00387	CbGpPWpGaD
Lorazepam—Chlorprothixene—HTR2A—Alzheimer's disease	0.000394	0.0247	CrCbGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PLCB1—Alzheimer's disease	0.000393	0.00383	CbGpPWpGaD
Lorazepam—Diazepam—PTGS1—Alzheimer's disease	0.000393	0.0246	CrCbGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—SST—Alzheimer's disease	0.000392	0.00382	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—NTRK2—Alzheimer's disease	0.000392	0.00382	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNB2—Alzheimer's disease	0.000392	0.00381	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000372	0.00362	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GRIA1—Alzheimer's disease	0.000369	0.0036	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000365	0.00356	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000365	0.00356	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—BDNF—Alzheimer's disease	0.000364	0.00354	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GRIA1—Alzheimer's disease	0.000362	0.00353	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—ACHE—Alzheimer's disease	0.00036	0.0035	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000358	0.00349	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000356	0.00347	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CHRNA4—Alzheimer's disease	0.000356	0.00346	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GRIK2—Alzheimer's disease	0.000355	0.00346	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CHAT—Alzheimer's disease	0.000355	0.00346	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.00035	0.00341	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CHRNB2—Alzheimer's disease	0.000349	0.00341	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000348	0.00339	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000344	0.00336	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CHRNB2—Alzheimer's disease	0.000343	0.00334	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000342	0.00333	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	0.000339	0.0033	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000338	0.0033	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MEF2C—Alzheimer's disease	0.000338	0.00329	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	0.000333	0.00324	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—NGF—Alzheimer's disease	0.000323	0.00314	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—ACHE—Alzheimer's disease	0.000321	0.00313	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—SLC30A6—Alzheimer's disease	0.000319	0.00311	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CHRNA4—Alzheimer's disease	0.000317	0.00309	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GRIA1—Alzheimer's disease	0.000317	0.00309	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000316	0.00308	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—ACHE—Alzheimer's disease	0.000315	0.00307	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—BCHE—Alzheimer's disease	0.000313	0.00305	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CHRNA4—Alzheimer's disease	0.000312	0.00304	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.00031	0.00302	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—DLG4—Alzheimer's disease	0.000306	0.00298	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—PPARGC1A—Alzheimer's disease	0.000301	0.00294	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CHRNB2—Alzheimer's disease	0.0003	0.00292	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—GRIN2B—Alzheimer's disease	0.000299	0.00291	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—PLCB1—Alzheimer's disease	0.000296	0.00288	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	0.000293	0.00286	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—BDNF—Alzheimer's disease	0.000293	0.00285	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—PRKCG—Alzheimer's disease	0.000291	0.00283	CbGpPWpGaD
Lorazepam—Clozapine—HTR2A—Alzheimer's disease	0.000289	0.0181	CrCbGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	0.000288	0.0028	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL1A—Alzheimer's disease	0.000281	0.00274	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—BCHE—Alzheimer's disease	0.00028	0.00272	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—ACHE—Alzheimer's disease	0.000276	0.00268	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—BCHE—Alzheimer's disease	0.000275	0.00268	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—DLG4—Alzheimer's disease	0.000273	0.00266	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CHRNA4—Alzheimer's disease	0.000272	0.00265	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—MEF2C—Alzheimer's disease	0.000272	0.00265	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—APOD—Alzheimer's disease	0.000271	0.00264	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—DLG4—Alzheimer's disease	0.000268	0.00261	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—GRIN2B—Alzheimer's disease	0.000267	0.0026	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—TPI1—Alzheimer's disease	0.000264	0.00258	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CHAT—Alzheimer's disease	0.000264	0.00258	CbGpPWpGaD
Lorazepam—Clozapine—CYP2D6—Alzheimer's disease	0.000264	0.0165	CrCbGaD
Lorazepam—GABRB3—Neuronal System—PLCB1—Alzheimer's disease	0.000264	0.00257	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—GRIN2B—Alzheimer's disease	0.000262	0.00255	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—NGF—Alzheimer's disease	0.00026	0.00253	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—PLCB1—Alzheimer's disease	0.000259	0.00252	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000255	0.00248	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MAOB—Alzheimer's disease	0.000253	0.00247	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CALM1—Alzheimer's disease	0.000252	0.00245	CbGpPWpGaD
Lorazepam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000251	0.00244	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.00025	0.00244	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—GSK3B—Alzheimer's disease	0.000247	0.00241	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—HTR2A—Alzheimer's disease	0.000247	0.00241	CbGpPWpGaD
Lorazepam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000246	0.0024	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—CREB1—Alzheimer's disease	0.000245	0.00239	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—GAPDH—Alzheimer's disease	0.000244	0.00238	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—BCHE—Alzheimer's disease	0.00024	0.00234	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—A2M—Alzheimer's disease	0.000236	0.0023	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—DLG4—Alzheimer's disease	0.000234	0.00228	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—GRIN2B—Alzheimer's disease	0.000229	0.00223	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—PLCB1—Alzheimer's disease	0.000227	0.00221	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.00022	0.00215	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—PRKCG—Alzheimer's disease	0.000219	0.00213	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000216	0.00211	CbGpPWpGaD
Lorazepam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CREB1—Alzheimer's disease	0.000215	0.0021	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ACHE—Alzheimer's disease	0.000205	0.002	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—INPP5D—Alzheimer's disease	0.000203	0.00197	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000198	0.00193	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CREB1—Alzheimer's disease	0.000198	0.00192	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—PRKCG—Alzheimer's disease	0.000195	0.0019	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.000195	0.0019	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ENO1—Alzheimer's disease	0.000192	0.00187	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTGS1—Alzheimer's disease	0.000192	0.00187	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—PRKCG—Alzheimer's disease	0.000192	0.00187	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CALM1—Alzheimer's disease	0.000189	0.00184	CbGpPWpGaD
Lorazepam—GABRB3—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000189	0.00184	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CYP2D6—Alzheimer's disease	0.000188	0.00184	CbGpPWpGaD
Lorazepam—GABRG2—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000185	0.0018	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—CASP3—Alzheimer's disease	0.000182	0.00177	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—BCHE—Alzheimer's disease	0.000179	0.00174	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—CP—Alzheimer's disease	0.00017	0.00166	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CALM1—Alzheimer's disease	0.000169	0.00165	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000169	0.00164	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PLCB1—Alzheimer's disease	0.000169	0.00164	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—PRKCG—Alzheimer's disease	0.000168	0.00163	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—MAPK8—Alzheimer's disease	0.000167	0.00163	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CALM1—Alzheimer's disease	0.000166	0.00162	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000166	0.00161	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—ABCA1—Alzheimer's disease	0.000163	0.00159	CbGpPWpGaD
Lorazepam—GABRA1—Transmission across Chemical Synapses—CREB1—Alzheimer's disease	0.000162	0.00158	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL1B—Alzheimer's disease	0.000147	0.00143	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—CASP3—Alzheimer's disease	0.000146	0.00142	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CALM1—Alzheimer's disease	0.000145	0.00141	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—TF—Alzheimer's disease	0.000145	0.00141	CbGpPWpGaD
Lorazepam—GABRB3—Neuronal System—CREB1—Alzheimer's disease	0.000145	0.00141	CbGpPWpGaD
Lorazepam—GABRG2—Neuronal System—CREB1—Alzheimer's disease	0.000142	0.00138	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARGC1A—Alzheimer's disease	0.000141	0.00137	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—HMOX1—Alzheimer's disease	0.00014	0.00137	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—LPL—Alzheimer's disease	0.000128	0.00125	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—VEGFA—Alzheimer's disease	0.000124	0.00121	CbGpPWpGaD
Lorazepam—GABRA1—Neuronal System—CREB1—Alzheimer's disease	0.000124	0.00121	CbGpPWpGaD
Lorazepam—GABRB3—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000118	0.00115	CbGpPWpGaD
Lorazepam—GABRG2—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000116	0.00113	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—MTHFR—Alzheimer's disease	0.000115	0.00112	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CALM1—Alzheimer's disease	0.000108	0.00105	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—APOE—Alzheimer's disease	0.000107	0.00105	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—CAV1—Alzheimer's disease	0.000106	0.00104	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—TNF—Alzheimer's disease	0.000106	0.00104	CbGpPWpGaD
Lorazepam—GABRA1—Transmembrane transport of small molecules—HMOX1—Alzheimer's disease	0.000101	0.000987	CbGpPWpGaD
Lorazepam—GABRB3—BDNF signaling pathway—AKT1—Alzheimer's disease	9.84e-05	0.000958	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PPARG—Alzheimer's disease	9.36e-05	0.000912	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—INS—Alzheimer's disease	9.18e-05	0.000894	CbGpPWpGaD
Lorazepam—GABRA1—SIDS Susceptibility Pathways—IL6—Alzheimer's disease	8.58e-05	0.000836	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—NOS3—Alzheimer's disease	8.05e-05	0.000784	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—PTGS2—Alzheimer's disease	7.36e-05	0.000717	CbGpPWpGaD
Lorazepam—UGT2B15—Metabolism—AKT1—Alzheimer's disease	3.7e-05	0.00036	CbGpPWpGaD
